Results 31 to 40 of about 487,451 (113)

Benefit of selinexor dose reduction on outcomes with selinexor, bortezomib and dexamethasone in patients with lenalidomide‐refractory multiple myeloma: Subgroup analysis of the BOSTON trial

open access: yesBritish Journal of Haematology, Volume 208, Issue 6, Page 2260-2264, June 2026.
A subgroup analysis of efficacy, safety and QOL in patients who received selinexor in combination with bortezomib and dexamethasone (SVd) with and without selinexor dose reduction and who had lenalidomide‐refractory disease in the phase 3 BOSTON trial showed improvements in efficacy, quality of life (QOL) and safety outcomes with selinexor dose ...
Sosana Delimpasi   +8 more
wiley   +1 more source

Innovative Aqueous Washing Agents for the Efficient Removal of Abamectin From Tomato (Solanum lycopersicum L.) Surface

open access: yesJournal of Food Process Engineering, Volume 49, Issue 4, April 2026.
This study presents an innovative and sustainable aqueous washing solution based on sodium dodecyl sulfate (SDS), capable of efficiently removing the pesticide abamectin from tomato surfaces. The method is reusable, preserves fruit integrity, and shows excellent potential for large‐scale industrial and domestic applications in fruit and vegetable ...
Isabela N. Souza   +6 more
wiley   +1 more source

LA INDUSTRIA FARMACÉUTICA ESPAÑOLA: ANÁLISIS MEDIANTE LA PERSPECTIVA DE GRUPOS ESTRATÉGICOS 2000-2003

open access: yesRevista Visión Gerencial, 2007
La industria farmacéutica española ha sufrido una importante transformación durante los últimos años. Para sobrevivir a estas nuevas condiciones de mercado, las empresas han redimensionado sus estrategias competitivas hacia actividades de Investigación ...
Enzo Piña
doaj  

India's Health Diplomacy: Advancing Pharmaceutical and MedTech Leadership in the Global South

open access: yesWorld Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Health diplomacy has become a pivotal aspect of India's engagement with the Global South, intertwining foreign policy, public health, and global collaboration to address disparities while pursuing strategic interests. India's pharmaceutical industry, which accounts for nearly 20% of the world's generics, has positioned the nation as the ...
Gaurav Chanderprakash Mittal   +4 more
wiley   +1 more source

Una empresa tradicional del sector de medicamentos en Colombia : el caso de farmacia y droguería garcés, 1876-1930.

open access: yesPanorama Económico, 2019
Este artículo tiene como objetivo presentar el desarrollo empresarial generado por una firma dedicada al mercado de medicamentos en Colombia a finales del siglo XIX y durante los tres primeros decenios del XX.
María Fernanda Erazo Obando
doaj   +3 more sources

Hematopoietic effects of tagraxofusp in treatment‐naive patients with blastic plasmacytoid dendritic cell neoplasm

open access: yesCancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an aggressive hematologic neoplasm that expresses CD123, is often observed in the bone marrow (BM), as well as skin, blood, and viscera. Tagraxofusp, a first‐in‐class CD123‐targeted therapy, is the only drug approved to treat BPDCN.
Marina Konopleva   +10 more
wiley   +1 more source

Programa Dáder: entrevista farmacéutica medicamentos

open access: yes, 2007
Formulario de la entrevista farmacéutica sobre medicamentos para el seguimiento ...
Grupo de Investigación de Atención Farmacéutica (GIAF)
core   +1 more source

La industria farmacéutica en Argentina y su transformación hacia una industria más flexible e innovadora [PDF]

open access: yes, 2021
La industria farmacéutica es una de las más grandes y prosperas a nivel mundial. En Argentina, no es la excepción. A diferencia de otras industrias donde no todos los grandes players mundiales dicen presente en el país, en la industria farmacéutica ...
Muntricas, Jorge
core   +1 more source

Análisis de una implementación RFID dentro de la industria farmacéutica

open access: yesIngenierías USBMed, 2017
¿Cuál o cuáles serían los mecanismos para apoyar a la industria farmacéutica en cuanto a la mejora de sus procesos con herramientas tecnológicas para combatir los medicamentos espurios? Ante este planteamiento se enfrentan las sociedades a nivel mundial,
Miguel Ángel Leguizamón Páez   +2 more
doaj   +1 more source

Quality Infrastructure for Resilient Pharmaceutical Manufacturing in Ethiopia: A Comparative Archival Review

open access: yesJournal of Critical Infrastructure Policy, Volume 7, Issue 1, Spring/Summer 2026.
ABSTRACT The National Quality Infrastructure (NQI) in a given country provides the essential framework for quality assurance integrating standardization, metrology, accreditation, and conformity assessment to create the technical backbone for industry and trade. Hence, building a resilient NQI is fundamental to securing medicine quality, enabling local
Addisu Afrassa Tegegne   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy